Moreover, dual blockade of PD-1 and cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) has demonstrated efficacy in chemotherapy-refractory GTN patients (DART SWOG 1609, NCT03135769) [35]. The gene discussed is PDCD1; the disease is gestational trophoblastic neoplasm.